SCHEMBL20101476

SCHEMBL20101476

c1ccc(N(c2ccncc2)c2cc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)cc(N(c3ccccc3)c3cccnc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPY5R Q15761 3/20 0.37
SLC6A2 P23975 2/20 0.34
CYP1A2 P05177 3/20 0.34
METAP2 P50579 2/20 0.34
MDM2 Q00987 1/20 0.34
PTGER4 P35408 1/20 0.33
ICMT O60725 1/20 0.33
MAPT P10636 2/20 0.32
TSPO P30536 1/20 0.32
DRD2 P14416 1/20 0.32
DYRK1A Q13627 1/20 0.32
CYP3A4 P08684 2/20 0.31
POLB P06746 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MEN1 O00255 1/20 0.31
HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19382987 0.97 KDM4E (0.41) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL23733283 0.91 KDM4E (0.36) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL17464016 0.90 KDM4E (0.41) KDM4EATML3MBTL1CYP1A2METAP2
SCHEMBL20101438 0.89 KDM4E (0.42) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL19382932 0.87 KDM4E (0.38) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL12061142 0.86 L3MBTL1 (0.51) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL15306409 0.85 KDM4E (0.43) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL15909826 0.85 KDM4E (0.37) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL23059771 0.85 CYP3A4 (0.39) KDM4EATML3MBTL1NPY5RCYP1A2
SCHEMBL16311285 0.85 L3MBTL1 (0.50) KDM4EATML3MBTL1NPY5RCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180123051-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed
US-20180123051-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180123051-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, ORAI2, OR10J3 KDM4E 1506/4885ATM 4024/4885L3MBTL1 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.